Eczema drug interaction study completed
NCT ID NCT06686628
First seen Feb 01, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study looked at how a new medicine called amlitelimab affects the way the body processes other drugs in adults with moderate-to-severe atopic dermatitis (eczema). 23 participants took part. The goal was to understand potential drug interactions to ensure safe use with other medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 2760001
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.